Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to antipsychotic treatment in patients with schizophrenia

Neuroscience Letters

Volumn 506, Issue 1, 2012, Pages 170-174

  Crisafulli, Concetta ^a   Chiesa, Alberto ^b   De Ronchi, Diana ^b   Han, Changsu ^c   Lee, Soo Jung ^d   Park, Moon Ho ^c   Patkar, Ashwin A ^e   Pae, Chi Un ^d,e   Serretti, Alessandro ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Korea University College of Medicine   (South Korea)

^d The Catholic University of Korea   (South Korea)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antipsychotics; Glutamate receptors; GRIA1; GRIA2; GRIA4; Schizophrenia

Indexed keywords

AMISULPRIDE; GLUTAMATE RECEPTOR 1; GLUTAMATE RECEPTOR 2; GLUTAMATE RECEPTOR 4; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; CHI-SQUARE DISTRIBUTION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, AMPA; SCHIZOPHRENIA;

EID: 84855195512     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.10.074     Document Type: Article

References (47)

1. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (Oxford, England) 2005, 21:263-265.
2. Beneyto M., Kristiansen L.V., Oni-Orisan A., McCullumsmith R.E., Meador-Woodruff J.H. Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders. Neuropsychopharmacology 2007, 32:1888-1902.
3. Brene S., Messer C., Nestler E.J. Expression of messenger RNAs encoding ionotropic glutamate receptors in rat brain: regulation by haloperidol. Neuroscience 1998, 84:813-823.
4. Carlsson M.L., Carlsson A., Nilsson M. Schizophrenia: from dopamine to glutamate and back. Current Medicinal Chemistry 2004, 11:267-277.
5. Cavalli-Sforza The History and Geography of Human Genes 1994, Princeton University Press, NJ, USA.
6. Cohen J. Statistical Power Analysis for the Behavioral Sciences 1988, Lawrence Erlbaum Associates, Hillsdale, NJ.
7. Coyle J.T. Glutamate and schizophrenia: beyond the dopamine hypothesis. Cellular and Molecular Neurobiology 2006, 26:365-384.
8. Din N., Ahmad I., Ul Haq I., Elahi S., Hoessli D.C., Shakoori A.R. The function of GluR1 and GluR2 in cerebellar and hippocampal LTP and LTD is regulated by interplay of phosphorylation and O-GlcNAc modification. Journal of Cellular Biochemistry 2010, 109:585-597.
9. Drago A., De Ronchi D., Serretti A. Incomplete coverage of candidate genes: a poorly considered bias. Current Genomics 2007, 8:476-483.
10. Du J., Creson T.K., Wu L.J., Ren M., Gray N.A., Falke C., Wei Y., Wang Y., Blumenthal R., Machado-Vieira R., Yuan P., Chen G., Zhuo M., Manji H.K. The role of hippocampal GluR1 and GluR2 receptors in manic-like behavior. Journal of Neuroscience 2008, 28:68-79.
11. Ekholm J.M., Kieseppa T., Hiekkalinna T., Partonen T., Paunio T., Perola M., Ekelund J., Lonnqvist J., Pekkarinen-Ijas P., Peltonen L. Evidence of susceptibility loci on 4q32 and 16p12 for bipolar disorder. Human Molecular Genetics 2003, 12:1907-1915.
12. Fitzgerald L.W., Deutch A.Y., Gasic G., Heinemann S.F., Nestler E.J. Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs. Journal of Neuroscience 1995, 15:2453-2461.
13. Freedman R. Schizophrenia. The New England Journal of Medicine 2003, 349:1738-1749.
14. Fukumaki Y., Shibata H. Glutamate receptor genes as candidates for schizophrenia susceptibility. Drug Development Research 2003, 60:137-151.
15. Ghosh A., Chakraborty K., Mattoo S.K. Newer molecules in the treatment of schizophrenia: a clinical update. Indian Journal of Pharmacology 2011, 43:105-112.
16. Giegling I., Drago A., Dolzan V., Plesnicar B.K., Schafer M., Hartmann A.M., Sander T., Toliat M.R., Moller H.J., Stassen H.H., Rujescu D., Serretti A. Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol. Pharmacogenetics and Genomics 2011, 21(4):206-216.
17. Guo S., Shi Y., Zhao X., Duan S., Zhou J., Meng J., Yang Y., Gu N., Feng G., Liu H., Zhu S., He L. No genetic association between polymorphisms in the AMPA receptor subunit GluR4 gene (GRIA4) and schizophrenia in the Chinese population. Neuroscience Letters 2004, 369:168-172.
18. Harrison P.J., Law A.J., Eastwood S.L. Glutamate receptors and transporters in the hippocampus in schizophrenia. Annals of the New York Academy of Sciences 2003, 1003:94-101.
19. Hovatta I., Varilo T., Suvisaari J., Terwilliger J.D., Ollikainen V., Arajarvi R., Juvonen H., Kokko-Sahin M.L., Vaisanen L., Mannila H., Lonnqvist J., Peltonen L. A genomewide screen for schizophrenia genes in an isolated Finnish subpopulation, suggesting multiple susceptibility loci. American Journal of Human Genetics 1999, 65:1114-1124.
20. Ibrahim H.M., Hogg A.J., Healy D.J., Haroutunian V., Davis K.L., Meador-Woodruff J.H. Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia. The American Journal of Psychiatry 2000, 157:1811-1823.
21. Javitt D.C. Glutamate and schizophrenia: phencyclidine, N-methyl-d-aspartate receptors, and dopamine-glutamate interactions. International Review of Neurobiology 2007, 78:69-108.
22. Kay S.R., Fiszbein A., Vital-Herne M., Fuentes L.S. The Positive and Negative Syndrome Scale - Spanish adaptation. The Journal of Nervous and Mental Disease 1990, 178:510-517.
23. Kerner B., Jasinska A.J., DeYoung J., Almonte M., Choi O.W., Freimer N.B. Polymorphisms in the GRIA1 gene region in psychotic bipolar disorder. American Journal of Medical Genetics: Neuropsychiatric Genetics 2009, 150B:24-32.
24. Konradi C., Heckers S. Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment. Pharmacology & Therapeutics 2003, 97:153-179.
25. Kraft P. Curses - winner's and otherwise - in genetic epidemiology. Epidemiology (Cambridge, Mass) 2008, 19:649-651. discussion 657-648.
26. Leucht S., Davis J.M., Engel R.R., Kane J.M., Wagenpfeil S. Defining 'response' in antipsychotic drug trials: recommendations for the use of scale-derived cutoffs. Neuropsychopharmacology 2007, 32:1903-1910.
27. Lim C., Chong S.A., Keefe R.S. Psychosocial factors in the neurobiology of schizophrenia: a selective review. Annals of the Academy of Medicine, Singapore 2009, 38:402-406.
28. Magri C., Gardella R., Barlati S.D., Podavini D., Iatropoulos P., Bonomi S., Valsecchi P., Sacchetti E., Barlati S. Glutamate AMPA receptor subunit 1 gene (GRIA1) and DSM-IV-TR schizophrenia: a pilot case-control association study in an Italian sample. American Journal of Medical Genetics: Neuropsychiatric Genetics 2006, 141B:287-293.
29. Magri C., Gardella R., Valsecchi P., Barlati S.D., Guizzetti L., Imperadori L., Bonvicini C., Tura G.B., Gennarelli M., Sacchetti E., Barlati S. Study on GRIA2, GRIA3 and GRIA4 genes highlights a positive association between schizophrenia and GRIA3 in female patients. American Journal of Medical Genetics: Neuropsychiatric Genetics 2008, 147B:745-753.
30. Makino C., Fujii Y., Kikuta R., Hirata N., Tani A., Shibata A., Ninomiya H., Tashiro N., Shibata H., Fukumaki Y. Positive association of the AMPA receptor subunit GluR4 gene (GRIA4) haplotype with schizophrenia: linkage disequilibrium mapping using SNPs evenly distributed across the gene region. American Journal of Medical Genetics: Neuropsychiatric Genetics 2003, 116B:17-22.
31. McCoy L., Cox C., Richfield E.K. Antipsychotic drug regulation of AMPA receptor affinity states and GluR1, GluR2 splice variant expression. Synapse (New York, NY) 1998, 28:195-207.
32. McGuffin P., Owen M.J., Farmer A.E. Genetic basis of schizophrenia. Lancet 1995, 346:678-682.
33. McInnis M.G., Lan T.H., Willour V.L., McMahon F.J., Simpson S.G., Addington A.M., MacKinnon D.F., Potash J.B., Mahoney A.T., Chellis J., Huo Y., Swift-Scanlan T., Chen H., Koskela R., Stine O.C., Jamison K.R., Holmans P., Folstein S.E., Ranade K., Friddle C., Botstein D., Marr T., Beaty T.H., Zandi P., DePaulo J.R. Genome-wide scan of bipolar disorder in 65 pedigrees: supportive evidence for linkage at 8q24, 18q22, 4q32, 2p12, and 13q12. Molecular Psychiatry 2003, 8:288-298.
34. Meador-Woodruff J.H., Healy D.J. Glutamate receptor expression in schizophrenic brain. Brain Research. Brain Research Reviews 2000, 31:288-294.
35. Nakagawa T. The biochemistry, ultrastructure, and subunit assembly mechanism of AMPA receptors. Molecular Neurobiology 2010, 42:161-184.
36. Norton N., Williams H.J., Owen M.J. An update on the genetics of schizophrenia. Current Opinion in Psychiatry 2006, 19:158-164.
37. O'Connor J.A., Muly E.C., Arnold S.E., Hemby S.E. AMPA receptor subunit and splice variant expression in the DLPFC of schizophrenic subjects and rhesus monkeys chronically administered antipsychotic drugs. Schizophrenia Research 2007, 90:28-40.
38. Rapoport J.L., Addington A.M., Frangou S., Psych M.R. The neurodevelopmental model of schizophrenia: update 2005. Molecular Psychiatry 2005, 10:434-449.
39. Schmitt W.B., Sprengel R., Mack V., Draft R.W., Seeburg P.H., Deacon R.M., Rawlins J.N., Bannerman D.M. Restoration of spatial working memory by genetic rescue of GluR-A-deficient mice. Nature Neuroscience 2005, 8:270-272.
40. Seelan R.S., Khalyfa A., Lakshmanan J., Casanova M.F., Parthasarathy R.N. Deciphering the lithium transcriptome: microarray profiling of lithium-modulated gene expression in human neuronal cells. Neuroscience 2008, 151:1184-1197.
41. Serretti A., Chiesa A., Porcelli S., Han C., Patkar A.A., Lee S.J., Park M.H., Pae C.U. Influence of TPH2 variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia. Psychiatry Research 2011.
42. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. The Journal of Clinical Psychiatry 1998, 59(Suppl. 20):22-33. quiz 34-57.
43. StatSoft I. STATISTICA per Windows 1995, StatSoft Italia srl.
44. Stone J.M., Morrison P.D., Pilowsky L.S. Glutamate and dopamine dysregulation in schizophrenia - a synthesis and selective review. Journal of Psychopharmacology (Oxford, England) 2007, 21:440-452.
45. Tamminga C.A., Lahti A.C., Medoff D.R., Gao X.M., Holcomb H.H. Evaluating glutamatergic transmission in schizophrenia. Annals of the New York Academy of Sciences 2003, 1003:113-118.
46. Tastemir D., Demirhan O., Sertdemir Y. Chromosomal fragile site expression in Turkish psychiatric patients. Psychiatry Research 2006, 144:197-203.
47. Tsai G., Coyle J.T. Glutamatergic mechanisms in schizophrenia. Annual Review of Pharmacology and Toxicology 2002, 42:165-179.